HER.CAR-CMV-specific-CTLs

N/A

Report date: 2022/01/14 13:23:58

Base Information

Drug NameHER.CAR-CMV-specific-CTLs

Drug Alias NameHER.CAR-CMV-specific-CTLs

ClassificationCell and gene therapy > Cell therapy > Immune system cell therapy > Lymphocytes therapy > T-lymphocyte cell therapy > Chimeric antigen receptor T cell therapyCell and gene therapy > Gene therapy

Mechanisms of ActionReceptor protein-tyrosine kinase erbB-2 modulatorsT lymphocyte replacements

TargetsReceptor protein-tyrosine kinase erbB-2

Therapy Area/IndicationsGlioblastoma

Global Approved IndicationsN/A

Approved Indications in ChinaN/A

Original Approved Country/TerritoryN/A

Original Approved DateN/A

Country/TerritoryUnited States

CombinationsNo

Global Highest StatusPhase 1 Clinical

Highest Status in ChinaN/A

Originator CompaniesBaylor College Of Medicine

China Registration ClassN/A

Develop Information

Active CompaniesMethodist Hospital System Texas Children'S Hospital Baylor College Of Medicine

Inactive CompaniesN/A

Active IndicationsGlioblastoma

Inactive IndicationsN/A

Other Information

ATC CodeN/A